Andrew J. Schwab bought $10.0M of CAMP4 THERAPEUTICS (CAMP)

Executed Oct 15 2024, disclosed Oct 15 2024, the same day.

Value, as filed

$10.0M

909,090 sh × $11.00

Executed

Oct 15 2024

the trade date, as filed

Disclosed

Oct 15 2024

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+20.8%

+20.8% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 15 2024), the stock returned +20.8% (delay-adjusted); from the execution session (Oct 15 2024), +20.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

Andrew J. Schwab Director profile →

Andrew J. Schwab (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). The largest single filing was $1.6M of CAMP (400,000 sh × $4.04, as filed), executed Aug 27.

The name

CAMP

CAMP4 THERAPEUTICS CORPORATION CAMP · Healthcare · 13 filings in 24 months ticker →

Healthcare · Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew J. Schwab in CAMP

CAMPSALE CAMP4 THERAPEUTICS CORPORATION $1.6M
400,000 sh × $4.04
Exec Aug 27
Filed Aug 31 · 5:05 PM ET CAMPSALE CAMP4 THERAPEUTICS CORPORATION $880K
191,865 sh across 3 lots
Exec Aug 19
Filed Aug 21 · 4:59 PM ET